[1]
“Factors Associated with Persistent Efficacy of Abrocitinib without Flare: A Multivariable Analysis of the JADE-REGIMEN Study”, J of Skin, vol. 8, no. 2, p. s378, Mar. 2024, doi: 10.25251/skin.8.supp.378.